fda glp-1 news november 2025 The medical cycle was anything but quiet. ⬇️ The Trump administration's significant changes to U.S. healthcare policy dominated headlines in 2025 and comprised many of MedPage Today's most-read stories. In FDA Decisions Expected: October 2025

Reny, Genve (Mdecine interne gnrale)

Phase 2 subjects on 150mg/day averaged 13.8% weight loss with no muscle loss reported

In the present study, the cecal microbiome differed significantly across treatment groups, despite tightly controlling for several variables known to alter the microbiome in rodents

Credentials Breakdown LegitScript Certification Verified LegitScript certification is the industry gold standard for online healthcare providers, and Belles certification shows it meets rigorous standards for safety, compliance, and trustworthy online practices

Liposomal forms are shown to be superior in absorption